OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials
Hamzah Bakouni, Heidar Sharafi, Arash Bahremand, et al.
Drug and Alcohol Dependence (2023) Vol. 253, pp. 111018-111018
Closed Access | Times Cited: 8
Hamzah Bakouni, Heidar Sharafi, Arash Bahremand, et al.
Drug and Alcohol Dependence (2023) Vol. 253, pp. 111018-111018
Closed Access | Times Cited: 8
Showing 8 citing articles:
Attitudes and Perspectives of Service Providers on Persons Who Use Stimulants in Northern and Central Mexico
Claudia Rafful, Leonardo Jiménez-Rivagorza, Daniela Peralta, et al.
Substance Use & Addiction Journal (2025)
Closed Access
Claudia Rafful, Leonardo Jiménez-Rivagorza, Daniela Peralta, et al.
Substance Use & Addiction Journal (2025)
Closed Access
Trial protocol of an open-label pilot study of oral naltrexone–bupropion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial)
Krista J. Siefried, Liam Acheson, Brendan Clifford, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e092032-e092032
Open Access
Krista J. Siefried, Liam Acheson, Brendan Clifford, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e092032-e092032
Open Access
Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT‐2 trial
Michael J. Li, Brendon Chau, Thomas R. Belin, et al.
Addiction (2024) Vol. 119, Iss. 10, pp. 1840-1845
Closed Access | Times Cited: 1
Michael J. Li, Brendon Chau, Thomas R. Belin, et al.
Addiction (2024) Vol. 119, Iss. 10, pp. 1840-1845
Closed Access | Times Cited: 1
Amphetamin-Konsumstörung: Benefit durch Bupropion-Behandlung?
Suchttherapie (2024) Vol. 25, Iss. 01, pp. 6-7
Closed Access
Suchttherapie (2024) Vol. 25, Iss. 01, pp. 6-7
Closed Access
Evaluation of reported claims of sex-based differences in treatment effects across meta-analyses: A meta-research study
Lum Kastrati, Sara Farina, A Valz Gris, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Lum Kastrati, Sara Farina, A Valz Gris, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Artificial intelligence‐based drug repurposing with electronic health record clinical corroboration: A case for ketamine as a potential treatment for amphetamine‐type stimulant use disorder
Zhenxiang Gao, Theresa Winhusen, Maria P. Gorenflo, et al.
Addiction (2024)
Closed Access
Zhenxiang Gao, Theresa Winhusen, Maria P. Gorenflo, et al.
Addiction (2024)
Closed Access
Is Naltrexone Effective and Safe for Treating Amphetamine-Type Stimulant Use Disorder? A Systematic Review and Meta-analysis
Gabriel Bastien, Christina McAnulty, Heidar Sharafi, et al.
Journal of Addiction Medicine (2024)
Closed Access
Gabriel Bastien, Christina McAnulty, Heidar Sharafi, et al.
Journal of Addiction Medicine (2024)
Closed Access
Drugs with addiction potential
Ivana Tašková, PGDip PGDip
Medicína pro praxi (2024) Vol. 21, Iss. 5, pp. 302-305
Closed Access
Ivana Tašková, PGDip PGDip
Medicína pro praxi (2024) Vol. 21, Iss. 5, pp. 302-305
Closed Access
